
PFX
PhenixFIN Corp
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
42.9999
Open
42.9999
VWAP
42.01
Vol
603.00
Mkt Cap
84.95M
Low
42.3941
Amount
25.33K
EV/EBITDA(TTM)
14.14
Total Shares
2.02M
EV
222.60M
EV/OCF(TTM)
--
P/S(TTM)
3.28
PhenixFIN Corporation is an internally managed non-diversified closed-end management investment company. The Company’s investment objective is to generate current income and capital appreciation. It seeks to achieve this objective primarily through making loans, private equity investments in privately held companies. It may also make debt, equity or other investments in publicly traded companies. These investments may also include investments in other BDCs, closed-end funds or real estate investment trusts (REITs). It also pursues other strategic opportunities and invests in other assets or operates other businesses to achieve its investment objective, such as operating and managing an asset-based lending business. The portfolio generally consists of senior secured first-lien-term loans, senior secured second-lien-term loans, senior secured bonds, preferred equity and common equity. Its loan and other debt investments are primarily rated below investment grade or are unrated.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
5.82M
-3.39%
0.450
-5.92%
5.81M
-6.59%
0.430
-46.57%
5.82M
+4.47%
0.240
+2.48%
Estimates Revision
The market is revising No Change the revenue expectations for PhenixFIN Corporation (PFX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -14.14%.
Revenue Estimates for FY2025
No Change

0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Stock Price
Go Down

-14.14%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for PhenixFIN Corp (PFX.O) is 27.39, compared to its 5-year average forward P/E of 31.04. For a more detailed relative valuation and DCF analysis to assess PhenixFIN Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
31.04
Current PE
27.39
Overvalued PE
65.63
Undervalued PE
-3.56
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Overvalued
5Y Average PS
5.55
Current PS
43.00
Overvalued PS
9.99
Undervalued PS
1.10
Financials
Annual
Quarterly
FY2025Q3
YoY :
-48.98%
3.50M
Total Revenue
FY2025Q3
YoY :
-73.14%
1.16M
Operating Profit
FY2025Q3
YoY :
-157.40%
-1.50M
Net Income after Tax
FY2025Q3
YoY :
-157.36%
-0.74
EPS - Diluted
FY2025Q3
YoY :
-212.50%
-42.76
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
12
80.5K
USD
Months
3-6
12
98.8K
USD
Months
6-9
5
123.7K
USD
Months
0-12
7
738.4K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
12
80.5K
USD
Months
3-6
12
98.8K
USD
Months
6-9
5
123.7K
USD
Months
0-12
7
738.4K
USD
Months
PFX News & Events
Events Timeline
2024-12-17 (ET)
2024-12-17
05:12:02
PhenixFIN reports Q4 NAV per share $79.37 vs. $70.75 last year
Sign Up For More Events
Sign Up For More Events
News
9.5
05-07NASDAQ.COMPhenixFIN (PFX) Q2 Earnings and Revenues Lag Estimates
9.5
05-06NewsfilterPhenixFIN Corporation Announces Fiscal Second Quarter 2025 Financial Results
9.5
05-06NASDAQ.COMPhenixFIN Corporation Reports Second Quarter 2025 Financial Results and Updates on Credit Facility
Sign Up For More News
People Also Watch

AXTI
AXT Inc
10.440
USD
-4.92%

GSIT
GSI Technology Inc
7.510
USD
-10.17%

NUKK
Nukkleus Inc
4.850
USD
-7.09%

EDIT
Editas Medicine Inc
2.540
USD
-5.93%

ABOS
Acumen Pharmaceuticals Inc
1.810
USD
-7.18%

CRDL
Cardiol Therapeutics Inc
1.020
USD
-1.92%

FBRX
Forte Biosciences Inc
13.840
USD
-4.29%

PROV
Provident Financial Holdings Inc
15.590
USD
+0.58%

KNDI
Kandi Technologies Group Inc
1.020
USD
-1.92%

IMPP
Imperial Petroleum Inc
5.930
USD
-3.42%
FAQ
What is PhenixFIN Corp (PFX) stock price today?
The current price of PFX is 42.3941 USD — it has increased 0.67 % in the last trading day.





